Abstract
Introduction: Gender-affirming facial procedures are critical for reducing the mental health impact of gender dysphoria. Injectable neurotoxins and dermal fillers may be the only options for facial masculinization or feminization for many patients, including poor surgical candidates. However, the largest barrier to access is cost/insurance. This study aims to assess the extent of health insurance coverage of gender-affirming neurotoxin and filler procedures.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
